New combo therapy aims to keep early lung cancer at bay
NCT ID NCT03446547
First seen Apr 20, 2026 · Last updated May 12, 2026 · Updated 3 times
Summary
This study tested whether adding the drug durvalumab after precise radiation therapy (SBRT) helps people with early-stage lung cancer stay cancer-free longer. About 106 patients with stage I non-small cell lung cancer who could not have surgery were randomly assigned to receive either durvalumab every 4 weeks for a year or just follow-up. The main goal was to see if the drug delays cancer progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC, STAGE I are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dept of Oncology
Tampere, Finland
-
Dept of Oncology
Vaasa, Finland
-
Dept of Oncology
Oslo, Norway
-
Dept of Oncology
Trondheim, Norway
-
Dept of Oncology
Stockholm, Sweden
-
Dept of pulmonary medicine
Tromsø, Norway
-
Dept of pulmonary medicine
Gävle, Sweden
-
Dept of pulmonary medicine
Linköping, Sweden
-
Dept of pulmonary medicine
Lund, Sweden
-
Dept. of Oncology
Gothenburg, Sweden
-
Dept. of Oncology
Umeå, Sweden
-
Helsinki
Helsinki, Finland
-
Sunderbyn
Luleå, Sweden
-
Turku
Turku, Finland
-
Ålesund
Ålesund, Norway
Conditions
Explore the condition pages connected to this study.